Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naoe Goto
Observed names:
Goto Naoe,
N. Goto,
Naoe GOTO
Institution:
Fujita Health University
Observed institutions:
Yamagata University,
Fujita Health University,
Okayama University,
Gifu Municipal Hospital,
Gifu University Hospital,
Gifu University,
Nishimino Kosei Hospital,
Gihoku Kosei Hospital
show all 8
OpenAlex ID:
A5111501694
Works
109
Awards
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy for Diagnosis of Lymphoproliferative Disorders: Feasibility of Immunohistological, Flow Cytometric, and Cytogenetic Assessments
2011
·
Ichiro Yasuda
, Naoe Goto
, et al.
·
The American Journal of Gastroenterology
·
103
Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
2015
·
Nobuhiko Nakamura
, Takeshi Hara
, et al.
·
Annals of Hematology
·
101
Clinicopathologic analysis of IgG4-related skin disease
2012
·
Yasuharu Sato
, Mai Takeuchi
, et al.
·
Modern Pathology
·
89
PDF
Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP
2010
·
Soranobu Ninomiya
, Takeshi Hara
, et al.
·
Annals of Hematology
·
89
Serum concentration of L ‐kynurenine predicts the clinical outcome of patients with diffuse large B‐cell lymphoma treated with R‐CHOP
2009
·
Takeshi Yoshikawa
, Takeshi Hara
, et al.
·
European Journal Of Haematology
·
71
Duodenal follicular lymphoma: Comprehensive gene expression analysis with insights into pathogenesis
2014
·
Katsuyoshi Takata
, Motohiko Tanino
, et al.
·
Cancer Science
·
69
PDF
Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin?s lymphoma: in combination with the International Prognostic Index
2004
·
Hideko Goto
, Hisashi Tsurumi
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
66
Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens
2011
·
Naoe Goto
, Hisashi Tsurumi
, et al.
·
Annals of Hematology
·
62
Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation
2001
·
Naoe Goto
, Ichiro Yasuda
, et al.
·
Journal of Gastroenterology
·
60
A phase II study of a THP‐COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B‐cell lymphoma
2007
·
Hisashi Tsurumi
, Takeshi Hara
, et al.
·
Hematological Oncology
·
48
High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia
2015
·
Ryoko Mabuchi
, Takeshi Hara
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
47
Endoscopic ultrasound-guided fine needle aspiration biopsy for splenic tumor: a case series
2009
·
T. Iwashita
, I. Yasuda
, et al.
·
Endoscopy
·
47
Serum‐soluble tumor necrosis factor receptor 2 (sTNF‐R2) level determines clinical outcome in patients with aggressive non‐Hodgkin's lymphoma
2006
·
Naoe Goto
, Hisashi Tsurumi
, et al.
·
European Journal Of Haematology
·
39
Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas
2017
·
Yasuko Yamamoto
, Naoe Goto
, et al.
·
Clinica Chimica Acta
·
38
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
2022
·
Akinao Okamoto
, Hidetsugu Fujigaki
, et al.
·
Blood Advances
·
36
PDF
Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U)
2008
·
Jun-ichi Kitagawa
, Takeshi Hara
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
35
Fas and Fas ligand expression on germinal center type‐diffuse large B‐cell lymphoma is associated with the clinical outcome
2006
·
Yasushi Kojima
, Hisashi Tsurumi
, et al.
·
European Journal Of Haematology
·
34
PDF
Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B‐cell lymphoma and its subtypes
2005
·
Rumiko Watanuki‐Miyauchi
, Yasushi Kojima
, et al.
·
Pathology International
·
33
Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone
2012
·
Naoe Goto
, Hisashi Tsurumi
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
31
Predominant copper deficiency during prolonged enteral nutrition through a jejunostomy tube compared to that through a gastrostomy tube
2011
·
Shinji Nishiwaki
, Masahide Iwashita
, et al.
·
Clinical Nutrition
·
31
Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies
2010
·
Naoe Goto
, Takeshi Hara
, et al.
·
American Journal of Hematology
·
30
Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens
2011
·
Naoe Goto
, Hisashi Tsurumi
, et al.
·
European Journal Of Haematology
·
29
Phase II study of the tetrahydropyranyl adriamycin–cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma
2011
·
Senji Kasahara
, Takeshi Hara
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
28
Pathobiological properties of the ubiquitin ligase N edd4 L in melanoma
2013
·
Yusuke Kito
, Juncheng Bai
, et al.
·
International Journal of Experimental Pathology
·
26
Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice
2015
·
Nobuhiko Nakamura
, Takeshi Hara
, et al.
·
International Journal of Hematology
·
23
Show more works
View as search
Works count:
109
Citation count:
1,597
H-index:
24
I10-index:
37
Year
Topic
Type
